JXHS1600039 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Import Drug Application | 2016-04-06 | Roche Pharma(Schweiz) AG | Roche Pharma (Schweiz) AG | Certificate Issued | 2017-03-17 | view |
JYHB2001051 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Supplementary Application | 2020-06-29 | Roche Registration GmbH | Roche Registration GmbH | Filed | 2020-06-30 | view |
JYHB2300614 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Supplementary Application | 2023-10-28 | | | | | view |
JYHB1901554 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Supplementary Application | 2019-12-21 | Roche Registration GmbH | Roche Registration GmbH | Certificate Issued | 2020-02-24 | view |
JYHB1800793 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Supplementary Application | 2018-07-11 | Roche Registration GmbH | Roche Registration GmbH | Certificate Issued | 2018-08-20 | view |
JYHB2300612 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Supplementary Application | 2023-10-26 | | | | | view |
JYHB1701017 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | Supplementary Application | 2017-08-02 | Roche Pharma(Schweiz) AG | Roche Pharma (Schweiz) AG | Certificate Issued | 2017-12-14 | view |
JYHZ2100628 | 维莫非尼片 | vemurafenib | Tablet | Chemical Drugs | License Renew | 2021-09-17 | | | | | view |